BSE Live
Sep 29, 16:01Prev. Close
136.80
Open Price
131.50
Bid Price (Qty.)
135.00 (200)
Offer Price (Qty.)
138.65 (5)
NSE Live
Sep 29, 15:42Prev. Close
135.50
Open Price
142.27
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
135.16 (1598)
Balance Sheet of Brooks Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 29.46 | 26.25 | 24.70 | 24.70 | 24.70 | |
Total Share Capital | 29.46 | 26.25 | 24.70 | 24.70 | 24.70 | |
Reserves and Surplus | 85.61 | 43.28 | 32.08 | 40.30 | 39.51 | |
Total Reserves and Surplus | 85.61 | 43.28 | 32.08 | 40.30 | 39.51 | |
Total Shareholders Funds | 115.07 | 69.53 | 56.78 | 65.00 | 64.21 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.13 | 0.00 | 0.00 | 0.00 | 1.34 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 1.74 | 0.89 | 1.16 | 1.34 | 0.11 | |
Long Term Provisions | 0.88 | 0.93 | 1.46 | 1.65 | 1.54 | |
Total Non-Current Liabilities | 2.75 | 1.81 | 2.62 | 2.99 | 3.00 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 5.93 | 5.04 | 5.66 | 4.92 | 6.82 | |
Trade Payables | 13.62 | 15.44 | 23.37 | 25.75 | 13.39 | |
Other Current Liabilities | 2.34 | 1.92 | 2.67 | 4.06 | 4.96 | |
Short Term Provisions | 0.95 | 0.64 | 1.32 | 0.74 | 0.63 | |
Total Current Liabilities | 22.84 | 23.05 | 33.02 | 35.46 | 25.79 | |
Total Capital And Liabilities | 140.66 | 94.39 | 92.42 | 103.45 | 93.00 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 13.97 | 13.60 | 14.81 | 14.78 | 14.42 | |
Intangible Assets | 0.01 | 0.07 | 0.20 | 0.36 | 0.53 | |
Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 1.12 | 0.00 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 13.98 | 13.67 | 15.01 | 16.26 | 14.98 | |
Non-Current Investments | 90.52 | 46.86 | 46.85 | 46.84 | 46.81 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 2.28 | 2.81 | 2.96 | 3.32 | 3.35 | |
Total Non-Current Assets | 106.78 | 63.34 | 64.82 | 66.42 | 65.13 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 9.20 | 9.61 | 11.30 | 16.59 | 12.38 | |
Trade Receivables | 19.99 | 16.32 | 12.75 | 15.03 | 9.59 | |
Cash And Cash Equivalents | 1.25 | 0.69 | 1.08 | 1.08 | 0.88 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 3.43 | 4.43 | 2.47 | 4.34 | 5.01 | |
Total Current Assets | 33.88 | 31.05 | 27.61 | 37.04 | 27.87 | |
Total Assets | 140.66 | 94.39 | 92.42 | 103.45 | 93.00 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 72.29 | 20.84 | 24.79 | 29.70 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | 9.12 | 9.12 | 9.12 | 9.12 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | 46.86 | 46.85 | 46.84 | 46.81 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.03.2025
Brooks Labs Consolidated December 2024 Net Sales at Rs 38.45 crore, up 76.8% Y-o-Y
18.11.2024
Brooks Labs Standalone September 2024 Net Sales at Rs 20.79 crore, down 14.49% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.03.2025
Brooks Labs Consolidated December 2024 Net Sales at Rs 38.45 crore, up 76.8% Y-o-Y
18.11.2024
Brooks Labs Standalone September 2024 Net Sales at Rs 20.79 crore, down 14.49% Y-o-Y